Walgreens has sold more shares of drug distributor Cencora for proceeds of about $400 million, which ... [+] will be used for "debt paydown and general corporate purposes."In this 2013 photo, a sign marks the entrance to a Walgreens store in San Francisco's upscale Union Square shopping district. (Photo by Robert Alexander/Getty Images) Getty Images The stock sale, which comes as chief executive officer Tim Wentworth works on a financial turnaround of the iconic drugstore chain, brings Walgreens stake in Ce ...

For the quarter ended March 2024, Cencora (COR) reported revenue of $68.41 billion, up 7.8% over the same period last year. EPS came in at $3.80, compared to $3.50 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $70.35 billion, representing a surprise of -2.75%. The company delivered an EPS surprise of +4.11%, with the consensus EPS estimate being $3.65.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expect ...

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Actual amounts could differ from these estimated amounts. Certain reclassifications have been made to prior-period amounts in order to conform to the current year presentation. The purchase price exceeded the estimated fair value of the net tangible and intangible assets acquired by $1,010.2 million, which ...

Cencora, Inc. (NYSE:COR) Q2 2024 Earnings Call Transcript May 1, 2024 8:30 AM ET Company Participants Bennett Murphy - SVP, Head of IR and Treasury Steve Collis - Chairman, President, and CEO Bob Mauch - EVP and COO Jim Cleary - EVP and CFO Conference Call Participants Elizabeth Anderson - Evercore Lisa Gill - JPMorgan Daniel Grosslight - Citi Eric Percher - Nephron Research Allen Lutz - Bank of America Stephanie Davis - Barclays Charles Rhyee - TD Cowen Michael Cherny - Leerink George Hill - Deutsche Bank ...

Adjusted free cash flow(1) ~$2.5 billion Fiscal 2024 guidance continued 11 initiatives to create healthier futures around the world • Completed business impact analyses for three of our largest businesses in the U.S., incorporating climate impact assessment results from previous years, as well as other elements across functional areas that impact business resilience • Launched a new training to empower all team members to support an inclusive work environment Embracing a culture of transparency, ethics, and ...

Cencora, Inc. (COR) reported second-quarter fiscal 2024 adjusted earnings per share (EPS) of $3.80, which beat the Zacks Consensus Estimate of 3.65 by 4.1%. The bottom line also improved 21% year over year.GAAP EPS was $2.09, up 27.9% from that reported in the year-ago period.Revenue DetailsRevenues totaled $68.4 billion, up 7.8% year over year. The top line, however, missed the Zacks Consensus Estimate by 2.8%.Segmental AnalysisU.S. Healthcare SolutionsRevenues in this segment totaled $61.3 billion, up 8.1 ...

Cencora (COR) came out with quarterly earnings of $3.80 per share, beating the Zacks Consensus Estimate of $3.65 per share. This compares to earnings of $3.50 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 4.11%. A quarter ago, it was expected that this prescription drug distributor would post earnings of $2.86 per share when it actually produced earnings of $3.28, delivering a surprise of 14.69%.Over the last four quarters, ...

• Interest Expense, Net: No adjustments were made to the GAAP presentation of net interest expense. In the second quarter of fiscal 2024, net interest expense of $64.1 million was flat compared to the prior year quarter. Interest expense increased as a result of increases in borrowings and interest rates associated with variable-rate debt offset, in part, by the September 30, 2023 divestiture of our less-than-wholly-owned subsidiary in Egypt. The increase in interest expense was offset by the increase in in ...

Wall Street analysts forecast that Cencora (COR) will report quarterly earnings of $3.65 per share in its upcoming release, pointing to a year-over-year increase of 4.3%. It is anticipated that revenues will amount to $70.35 billion, exhibiting an increase of 10.9% compared to the year-ago quarter.Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of th ...

Every portfolio needs a solid foundation of high-quality stocks that can provide steady returns through all market environments. While I often discuss more speculative growth and penny stock plays in my articles that some view as high-risk, high-reward bets, the core of your portfolio should revolve around a select few tried-and-true companies. We all know the big tech giants and other household names that seem to keep climbing higher. But today, I want to look beyond those ubiquitous stocks and highlight t ...